Literature DB >> 9777748

Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies.

A Allahabadia1, J M Heward, C Mijovic, J Carr-Smith, J Daykin, C Cockram, A H Barnett, M C Sheppard, J A Franklyn, S C Gough.   

Abstract

The thyrotropin receptor (TSH-R) gene is a candidate for genetic susceptibility to Graves' disease (GD). Previous case control studies investigating allelic association of a polymorphism at position 253 (C253 to A253) of the TSH-R gene have shown conflicting results. We genotyped two independent case control datasets (UK Caucasian and Hong Kong Chinese), for the A253 polymorphism. The Transmission Disequilibrium Test was also used in a third family-based dataset that included 89 UK Caucasian families (both parents, a GD sibling and an unaffected sibling). Genotyping was performed by polymerase chain reaction (PCR)-amplification of genomic DNA and Tth111 I restriction enzyme digestion. No difference in frequencies of the A253 polymorphism between GD (21/204, 10.3%) and controls (34/358, 9.5%) was found in the UK Caucasians (chi2 = 0.093; p = NS). A similar finding was observed in GD (0/96, 0%) and controls (2/71, 2.8%) in Hong Kong Chinese subjects (chi2 = 2.73; p = NS). Results from the 89 UK families showed no deviation from the expected transmission frequency of 0.5, from parents heterozygous for the A253 allele to either Graves' or unaffected offspring (Fisher's exact test p = 0.22) and, therefore, confirmed a lack of evidence of linkage disequilibrium between the A253 allele and GD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777748     DOI: 10.1089/thy.1998.8.777

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  13 in total

Review 1.  The genetics of the thyroid stimulating hormone receptor: history and relevance.

Authors:  Terry F Davies; Xiaoming Yin; Rauf Latif
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 2.  Genetic susceptibility to autoimmune thyroid disease: past, present, and future.

Authors:  Yaron Tomer
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

3.  TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.

Authors:  N E Bufalo; R B Dos Santos; M A Marcello; R P Piai; R Secolin; J H Romaldini; L S Ward
Journal:  J Endocrinol Invest       Date:  2014-12-28       Impact factor: 4.256

4.  Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.

Authors:  Xiaoming Yin; Rauf Latif; Rebecca Bahn; Yaron Tomer; Terry F Davies
Journal:  Thyroid       Date:  2008-11       Impact factor: 6.568

Review 5.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

Review 6.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

Review 7.  [Genetics of thyroid autoimmunity - update and clinical relevance].

Authors:  Georg Dultz; Manuela Dittmar; George J Kahaly
Journal:  Med Klin (Munich)       Date:  2009-04-01

Review 8.  Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.

Authors:  M J Simmonds; S C L Gough
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

9.  The etiology of autoimmune thyroid disease: a story of genes and environment.

Authors:  Yaron Tomer; Amanda Huber
Journal:  J Autoimmun       Date:  2009 May-Jun       Impact factor: 7.094

10.  Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts.

Authors:  Rafał Płoski; Oliver J Brand; Beata Jurecka-Lubieniecka; Maria Franaszczyk; Dorota Kula; Paweł Krajewski; Muhammad A Karamat; Matthew J Simmonds; Jayne A Franklyn; Stephen C L Gough; Barbara Jarząb; Tomasz Bednarczuk
Journal:  PLoS One       Date:  2010-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.